-
Je něco špatně v tomto záznamu ?
Antibiotic susceptibility and production of endotoxin by Ochrobactrum anthropi isolated from environment and from patients with cystic fibrosis
D. Chmelař, O. Holý, I. Kasáková, M. Hájek, A. Lazarová, C. Gonzalez-Rey, J. Lasák, V. Raclavský, I. Čižnár,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu srovnávací studie, časopisecké články
- MeSH
- antibakteriální látky farmakologie MeSH
- bakteriální léková rezistence MeSH
- cystická fibróza mikrobiologie MeSH
- dítě MeSH
- endotoxiny metabolismus MeSH
- gramnegativní bakteriální infekce mikrobiologie MeSH
- lidé MeSH
- Limulus test MeSH
- mikrobiální testy citlivosti MeSH
- mikrobiologie životního prostředí MeSH
- mladiství MeSH
- Ochrobactrum anthropi účinky léků izolace a purifikace metabolismus MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
The aim of this work was to compare production of endotoxin and to determine susceptibility to antibiotics in two groups of specimens-wild-type strains Ochrobactrum anthropi isolated from the environment and the strains isolated from patients with cystic fibrosis. The determination of the endotoxin produced by the test strains was carried on by using a limulus amebocyte lysate test (LAL test). Determination of ATB sensitivity was accomplished by means of a broth dilution method in a microtiter plate (MIC). No significant difference was found between the group of ochrobacters isolated from the environment and the group of ochrobacters isolated from cystic fibrosis patients. Antibiotic sensitivity testing has indicated that the resistance to tigecycline, trimethoprim/sulfamethoxazole, and gentamicin was slightly higher in strains isolated from cystic fibrosis patients in comparison with strains isolated from the environment. In general, most of the test strains were sensitive to most of the antibiotics tested. Significant resistance has been demonstrated for cefotaxime. Resistance was also found for gentamicin in strains number 4 and 7. The MIC was equal to the breakpoint for this antibiotic (8000 mg/L).
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20008026
- 003
- CZ-PrNML
- 005
- 20200605112930.0
- 007
- ta
- 008
- 200605s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-019-00700-8 $2 doi
- 035 __
- $a (PubMed)30919306
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Chmelař, Dittmar $u Department of Biomedical Sciences, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 245 10
- $a Antibiotic susceptibility and production of endotoxin by Ochrobactrum anthropi isolated from environment and from patients with cystic fibrosis / $c D. Chmelař, O. Holý, I. Kasáková, M. Hájek, A. Lazarová, C. Gonzalez-Rey, J. Lasák, V. Raclavský, I. Čižnár,
- 520 9_
- $a The aim of this work was to compare production of endotoxin and to determine susceptibility to antibiotics in two groups of specimens-wild-type strains Ochrobactrum anthropi isolated from the environment and the strains isolated from patients with cystic fibrosis. The determination of the endotoxin produced by the test strains was carried on by using a limulus amebocyte lysate test (LAL test). Determination of ATB sensitivity was accomplished by means of a broth dilution method in a microtiter plate (MIC). No significant difference was found between the group of ochrobacters isolated from the environment and the group of ochrobacters isolated from cystic fibrosis patients. Antibiotic sensitivity testing has indicated that the resistance to tigecycline, trimethoprim/sulfamethoxazole, and gentamicin was slightly higher in strains isolated from cystic fibrosis patients in comparison with strains isolated from the environment. In general, most of the test strains were sensitive to most of the antibiotics tested. Significant resistance has been demonstrated for cefotaxime. Resistance was also found for gentamicin in strains number 4 and 7. The MIC was equal to the breakpoint for this antibiotic (8000 mg/L).
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a cystická fibróza $x mikrobiologie $7 D003550
- 650 _2
- $a bakteriální léková rezistence $7 D024881
- 650 _2
- $a endotoxiny $x metabolismus $7 D004731
- 650 _2
- $a mikrobiologie životního prostředí $7 D004783
- 650 _2
- $a gramnegativní bakteriální infekce $x mikrobiologie $7 D016905
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Limulus test $7 D008033
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a Ochrobactrum anthropi $x účinky léků $x izolace a purifikace $x metabolismus $7 D020621
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Holý, Ondřej $u Department of Public Health, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15, Olomouc, Czech Republic. Holy.ondrej@seznam.cz.
- 700 1_
- $a Kasáková, Iveta $u Department of Biomedical Sciences, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Hájek, Michal $u Department of Biomedical Sciences, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Centre of Hyperbaric Medicine, Ostrava City Hospital, Ostrava, Czech Republic.
- 700 1_
- $a Lazarová, Anna $u Department of Biomedical Sciences, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Department of Immunology and Alergology, Public Health Institute Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Gonzalez-Rey, Carlos $u Swedish Orphan Biovitrum AB, Stockholm, Sweden.
- 700 1_
- $a Lasák, Jakub $u Department of Neonatology, University Hospital Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a Raclavský, Vladislav $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a Čižnár, Ivan $u Department of Biomedical Sciences, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Faculty of Public Health, Slovak Medical University in Bratislava, Bratislava, Slovak Republic.
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 64, č. 6 (2019), s. 861-865
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30919306 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20200605 $b ABA008
- 991 __
- $a 20200605112928 $b ABA008
- 999 __
- $a ok $b bmc $g 1531669 $s 1098099
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 64 $c 6 $d 861-865 $e 20190327 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- LZP __
- $a Pubmed-20200605
